D-0609-2025 Class II Ongoing

Recalled by Boothwyn Pharmacy LLC — Kennett Square, PA

FDA drug recall D-0609-2025 was initiated by Boothwyn Pharmacy LLC on Jul 9, 2025 and is designated Class II. Reason for recall: Subpotent Drug The recall status is ongoing. Affected quantity: 648 vials.

Recall details

Product Type
Drugs
Report Date
Sep 10, 2025
Initiation Date
Jul 9, 2025
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
648 vials

Product description

Semaglutide, 2.5 mg/mL injection, 4 mL, Boothwyn Pharmacy

Reason for recall

Subpotent Drug

Distribution pattern

U.S. Nationwide

Code information

03202025@2, 03202025@3 and 03202025@4 BUD 07/18/2025

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0609-2025
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0609-2025. Report a data issue: hello@regdatalab.com.